Branan Medical Corp.

Click Here To EMAIL INQUIRY
Web: http://www.brananmedical.com
E-Mail:
Address: 140 Technology, Suite 400, Irvine, California 92618, USA
Phone: +1-(949)-598-7166,866-468-3287 | Fax: +1-(949)-598-7167 | Map/Directions >>

Profile: Branan Medical Corp. is a manufacturer of products for drugs-of-abuse testing. We offer a complete line of rapid, on-site drug and adulteration tests in urine & oral fluids. Our products are accurate, precise and sensitive & are developed with lateral flow immunoassay technology. Our OratectPlus™ oral fluid drug & alcohol screen device detects drugs plus alcohol on the same device. It simultaneously tests for 6 drugs, which include marijuana, cocaine, opiates, amphetamine, methamphetamine and either PCP or benzodiazepines plus alcohol. The alcohol test correlates with 0.02% blood alcohol concentration. Monitect® is our FDA 510K cleared mutiple drug screen cassette that can simultaneously test for both drugs and adulterants. It can test from one to 5 drugs and can be accompanied with 4 adulterant tests.

The company is ISO 13485:2003, CE certified.

33 Products/Services (Click for related suppliers)

• Alcohol Containing Fixative (FDA Code: LDZ / 864.4010)

• Amphetamine Enzyme Immunoassay Test (FDA Code: DKZ / 862.3100)

An amphetamine test system is a device intended to measure amphetamine, a central nervous system stimulating drug, in plasma and urine. Measurements obtained by this device are used in the diagnosis and treatment of amphetamine use or overdose and in monitoring levels of amphetamine to ensure appropriate therapy.

• Amphetamine Test Strip

• Barbiturate Enzyme Immunoassay Test (FDA Code: DIS / 862.3150)

A barbiturate test system is a device intended to measure barbiturates, a class of hypnotic and sedative drugs, in serum, urine, and gastric contents. Measurements obtained by this device are used in the diagnosis and treatment of barbiturate use or overdose and in monitoring levels of barbiturate to ensure appropriate therapy.

• Barbiturates Test Device

• Benzodiazepine Enzyme Immunoassay Test (FDA Code: JXM / 862.3170)

A benzodiazepine test system is a device intended to measure any of the benzodiazepine compounds, sedative and hypnotic drugs, in blood, plasma, and urine. The benzodiazepine compounds include chlordiazepoxide, diazepam, oxazepam, chlorzepate, flurazepam, and nitrazepam. Measurements obtained by this device are used in the diagnosis and treatment of benzodiazepine use or overdose and in monitoring levels of benzodiazepines to ensure appropriate therapy.

• Benzodiazepines Test Strip

• Cannabinoids Enzyme Immunoassay Test (FDA Code: LDJ / 862.3870)

A cannabinoid test system is a device intended to measure any of the cannabinoids, hallucinogenic compounds endogenous to marihuana, in serum, plasma, saliva, and urine. Cannabinoid compounds includedelta -9-tetrahydrocannabinol, cannabidiol, cannabinol, and cannabichromene. Measurements obtained by this device are used in the diagnosis and treatment of cannabinoid use or abuse and in monitoring levels of cannabinoids during clinical investigational use.

• Cocaine and Cocaine Metabolites Enzyme Immunoassay Test (FDA Code: DIO / 862.3250)

A cocaine and cocaine metabolite test system is a device intended to measure cocaine and a cocaine metabolite (benzoylecgonine) in serum, plasma, and urine. Measurements obtained by this device are used in the diagnosis and treatment of cocaine use or overdose.

• Cocaine Test Strip

• Creatinine Adulteration Tests

• Drug Screen Cups

• Drugs Of Abuse Test Kits

• Ecstasy Test Devices

• Goat Antibody Morphine (125-I) Radioimmunoassay Test (FDA Code: DOE / 862.3640)

A morphine test system is a device intended to measure morphine, an addictive narcotic pain-relieving drug, and its analogs in serum, urine, and gastric contents. Measurements obtained by this device are used in the diagnosis and treatment of morphine use or overdose and in monitoring levels of morphine and its analogs to ensure appropriate therapy.

• Metamphetamine Thin Layer Chromatography Test (FDA Code: DJC / 862.3610)

A methamphetamine test system is a device intended to measure methamphetamine, a central nervous system stimulating drug, in serum, plasma, and urine. Measurements obtained by this device are used in the diagnosis and treatment of methamphetamine use or overdose.

• Methadone Enzyme Immunoassay Test (FDA Code: DJR / 862.3620)

A methadone test system is a device intended to measure methadone, an addictive narcotic pain-relieving drug, in serum and urine. Measurements obtained by this device are used in the diagnosis and treatment of methadone use or overdose and to determine compliance with regulations in methadone maintenance treatment.

• Methadone Test Strip

• Methamphetamine Gas Chromatography Test (FDA Code: LAF / 862.3610)

• Methamphetamine Test Strip

• Morphine Fluorometry Test (FDA Code: DJJ / 862.3640)

• Nitrite Adulteration Tests

• Opiates Enzyme Immunoassay Test (FDA Code: DJG / 862.3650)

An opiate test system is a device intended to measure any of the addictive narcotic pain-relieving opiate drugs in blood, serum, urine, gastric contents, and saliva. An opiate is any natural or synthetic drug that has morphine-like pharmocological actions. The opiates include drugs such as morphine, morphine glucoronide, heroin, codeine, nalorphine, and meperedine. Measurements obtained by this device are used in the diagnosis and treatment of opiate use or overdose and in monitoring the levels of opiate administration to ensure appropriate therapy.

• Phencyclidine Enzyme Immunoassay (FDA Code: LCM)

• Phencylindine Test Devices

• Testing Strips

• Thin Layer Chroomatography, Tricyclic Antidepressant Drugs (FDA Code: MLK / 862.3910)

A tricyclic antidepressant drugs test system is a device intended to measure any of the tricyclic antidepressant drugs in serum. The tricyclic antidepressant drugs include imipramine, desipramine, amitriptyline, nortriptyline, protriptyline, and doxepin. Measurements obtained by this device are used in the diagnosis and treatment of chronic depression to ensure appropriate therapy.

• Tricyclic Antidepressant Drugs Radioimmunoassay Test (FDA Code: LFG / 862.3910)

• Tricyclic Antidepressant Drugs U.V. Spectrometry (FDA Code: LFH / 862.3910)

• Tricyclic Antidepressants

• Urine Adulteration Test Strips

• Urine dipstick test Kit

• Urine Teststrips